LANTERN PHARMA INC.

Company

Lantern Pharma Inc.

Filed

January 25, 2021

Accession Number

0000902664-21-000498

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →